Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

LADX

LadRx (QB) (LADX)

LadRx Corporation (QB)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:LADX

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/02/2025	16:00	Edgar (US Regulatory)	Form SEC STAFF ACTION - SEC Staff Action: ORDER	USOTC:LADX	LadRx Corporation (QB)
14/11/2024	05:27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:LADX	LadRx Corporation (QB)
09/10/2024	05:04	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LADX	LadRx Corporation (QB)
20/08/2024	05:05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:LADX	LadRx Corporation (QB)
20/08/2024	05:03	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:LADX	LadRx Corporation (QB)
14/02/2024	13:49	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:LADX	LadRx Corporation (QB)
29/01/2024	15:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LADX	LadRx Corporation (QB)
11/01/2024	15:50	Dow Jones News	Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	USOTC:LADX	LadRx Corporation (QB)
12/10/2023	05:08	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:LADX	LadRx Corporation (QB)